Incorporating miRNAs into a taRNA vector platform with Drs. Tim Beissert and Ayşegül Yildiz - The Molecular Therapy Podcast
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Incorporating miRNAs into a taRNA vector platform with Drs. Tim Beissert and Ayşegül Yildiz - The Molecular Therapy Podcast
-
ナレーター：
-
著者：
このコンテンツについて
Drs. Ayşegül Yildiz and Tim Beissert join Dr. Paloma Giangrande to discuss a recent article published in Molecular Therapy Nucleic Acids by Drs. Yildiz. Beissert, and colleagues titled “Trans-amplifying RNA expressing functional miRNA mediates target gene suppression and simultaneous transgene expression”.
Are you registered for ASGCT’s 2025 Annual Meeting in New Orleans? Join us May 13-17 for the premier event in our field and save $465 as an ASGCT member. Check out the full program, plan your trip, and register for the ASGCT Annual Meeting by visiting annualmeeting.asgct.org.
In This Episode
Paloma Giangrande, PhD
Editor-in-chief of Molecular Therapy Nucleic Acids
Senior Vice President Discovery & Translational Biology, Orbital Therapeutics
Ayşegül Yildiz, PhD
Scientist of TRON’s Cardiovascular Therapeutics Group
Tim Beissert, PhD
Senior Scientist and Group Leader of TRON’s Vector Development and Gene Transfer Team
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.